By a GenomeWeb staff reporter
The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade.
Celera names Merriweather as SVP and CFO; TcLand Expression appoints Payne as CBO.
The French firm also said it has received $564,000 in funding for the project.
Patrick Terry, Lisa Wise, James O'Leary
Jack Lord is named president and CEO of Navigenics, while Celera has a new CFO, and Patrick Terry joins the board of directors of TcLand Expression, plus more.
A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.
Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.
In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.
Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.